Provided is a monoclonal antibodies that recognize CD47, more specifically to CD47 antibodies that do not cause a significant level of agglutination of cells, red blood cell depletion, amenia, and platelet depletion.
Figure 1A-1H is a series of graphs showing binding of humanized variants of 2A1 to Raji cells.
2A1-xi was used as an internal control on most graphs.
Figure 2 is a graph showing the phagocytic index, wherein antibodies used were the commercial antibody B6H12, the murine 2A1 antibody, a humanized variant AB2.05 antibody, and the non-blocking commercial antibody 2D3.
CCRF-CEM cells were used as the CD47 target cell line in these experiments.
Figure 3 is a graph showing the phagocytic index, wherein the antibodies used were the commercial antibody B6H12, humanized antibody AB2.05 (human IgG1), and the IgG1, IgG4P, and IgG4PE variants of the humanized antibody AB6.12.
CCRF-CEM cells were used as the CD47 target cell line in these experiments.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-278LC | Human Anti-CD47 Recombinant Antibody (TAB-278LC) | Block, FuncS | Human IgG, κ |
TAB-279LC | Human Anti-CD47 Recombinant Antibody (TAB-279LC) | Block, FuncS | Human IgG, κ |
TAB-278LC-S(P) | Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-278LC-S(P)) | ELISA | Human scFv |
TAB-278LC-F(E) | Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-278LC-F(E)) | ELISA | Human Fab |
TAB-279LC-F(E) | Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-279LC-F(E)) | ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-280LC | Human Anti-CD47 Recombinant Antibody (TAB-280LC) | ELISA | Humanized antibody |
TAB-281LC | Human Anti-CD47 Recombinant Antibody (TAB-281LC) | ELISA | Humanized antibody |
TAB-282LC | Human Anti-CD47 Recombinant Antibody (TAB-282LC) | ELISA | Humanized antibody |
TAB-283LC | Human Anti-CD47 Recombinant Antibody (TAB-283LC) | ELISA | Humanized antibody |
TAB-284LC | Human Anti-CD47 Recombinant Antibody (TAB-284LC) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-387CQ | Mouse Anti-CD47 Recombinant Antibody (clone CBL377) | Block, FC, CyTOF | Mouse IgG1 |
NEUT-388CQ | Mouse Anti-CD47 Recombinant Antibody (clone MIAP410) | Block, IF | Mouse IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-389CQ | Rat Anti-CD47 Recombinant Antibody (clone miap301) | FC, FuncS, Neut, WB | Rat IgG2a, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0565 | Hi-Affi™ Rabbit Anti-CD47 Recombinant Antibody (clone DS565AB) | WB, ICC, FC | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0092-CN | Mouse Anti-CD47 Recombinant Antibody (HPAB-0092-CN) | ELISA, FC | Mouse IgG1 |
HPAB-0094-CN | Human Anti-CD47 Recombinant Antibody (HPAB-0094-CN) | ELISA, FC | Humanized IgG2, κ |
HPAB-0095-CN | Human Anti-CD47 Recombinant Antibody (HPAB-0095-CN) | ELISA, FC | Humanized IgG1 |
HPAB-0096-CN | Human Anti-CD47 Recombinant Antibody (HPAB-0096-CN) | ELISA, FC, Neut | Humanized IgG |
HPAB-0097-CN | Human Anti-CD47 Recombinant Antibody (HPAB-0097-CN) | FC | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0834-CN-F(E) | Mouse Anti-CD47 Recombinant Antibody; Fab Fragment (HPAB-0834-CN-F(E)) | ELISA, FC, Neut | Mouse Fab |
HPAB-0835-CN-F(E) | Human Anti-CD47 Recombinant Antibody; Fab Fragment (HPAB-0835-CN-F(E)) | ELISA, FC, Neut | Chimeric (mouse/human) Fab |
HPAB-0836-CN-F(E) | Mouse Anti-CD47 Recombinant Antibody; Fab Fragment (HPAB-0836-CN-F(E)) | ELISA, FC, Neut | Mouse Fab |
HPAB-0837-CN-F(E) | Human Anti-CD47 Recombinant Antibody; Fab Fragment (HPAB-0837-CN-F(E)) | ELISA, FC, Neut | Chimeric (mouse/human) Fab |
HPAB-0838-CN-F(E) | Mouse Anti-CD47 Recombinant Antibody; Fab Fragment (HPAB-0838-CN-F(E)) | ELISA, FC, Neut | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-N0037-YC-S(P) | Human Anti-CD47 Recombinant Antibody (clone ZFlY1-93Y94P); scFv Fragment | ELISA, FC, Block | Humanized scFv |
HPAB-N0039-YC-S(P) | Human Anti-CD47 Recombinant Antibody; scFv Fragment (HPAB-N0039-YC-S(P)) | ELISA, FC, Block | Human scFv |
HPAB-N0040-YC-S(P) | Human Anti-CD47 Recombinant Antibody; scFv Fragment (HPAB-N0040-YC-S(P)) | ELISA | Human scFv |
HPAB-N0041-YC-S(P) | Human Anti-CD47 Recombinant Antibody; scFv Fragment (HPAB-N0041-YC-S(P)) | ELISA, Block | Human scFv |
HPAB-N0042-YC-S(P) | Human Anti-CD47 Recombinant Antibody; scFv Fragment (HPAB-N0042-YC-S(P)) | ELISA, Block | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-AP496-YC | Recombinant Alpaca Anti-CD47 Single Domain Antibody (A4) | FC, BL, FuncS | Alpaca VHH |
HPAB-AP497-YC | Recombinant Alpaca Anti-CD47 Single Domain Antibody (F2) | FC | Alpaca VHH |
HPAB-AP498-YC | Recombinant Alpaca Anti-CD47 Single Domain Antibody (H5) | FC, BL | Alpaca VHH |
HPAB-AP499-YC | Recombinant Alpaca Anti-CD47 Single Domain Antibody (H9) | FC, BL | Alpaca VHH |
NBD-0016-YJ-VHH | Camelid Anti-CD47 Recombinant Single Domain Antibody (Nb02) | ELISA, SPR | Camelid VHH |
There are currently no Customer reviews or questions for HPAB-AP035-YC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.